Ionis Pharmaceuticals, Inc.
MODULATORS OF ENaC EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting ENaC expression, which may be useful for treating, preventing, or ameliorating a disease associated with ENaC.
Status:
Application
Type:
Utility
Filling date:
31 Oct 2018
Issue date:
17 Jun 2021